SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-298745
Filing Date
2020-11-20
Accepted
2020-11-20 08:30:30
Documents
17
Period of Report
2020-12-18
Effectiveness Date
2020-11-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d36630ddef14a.htm DEF 14A 1138901
2 GRAPHIC g366301n.jpg GRAPHIC 8505
3 GRAPHIC g366302.jpg GRAPHIC 7653
4 GRAPHIC g36630g00a07.jpg GRAPHIC 62539
5 GRAPHIC g36630g00a08.jpg GRAPHIC 95872
6 GRAPHIC g36630g06m00.jpg GRAPHIC 128318
7 GRAPHIC g36630g07i30.jpg GRAPHIC 49301
8 GRAPHIC g36630g16m01.jpg GRAPHIC 32404
9 GRAPHIC g36630g16z66.jpg GRAPHIC 49680
10 GRAPHIC g36630g22y12.jpg GRAPHIC 102646
11 GRAPHIC g36630g42g86.jpg GRAPHIC 26599
12 GRAPHIC g36630g44t51.jpg GRAPHIC 57070
13 GRAPHIC g36630g52t54.jpg GRAPHIC 18454
14 GRAPHIC g36630g86s35.jpg GRAPHIC 52095
15 GRAPHIC g36630img03.jpg GRAPHIC 1674
16 GRAPHIC g36630img04.jpg GRAPHIC 1787
17 GRAPHIC g36630img05.jpg GRAPHIC 1838
  Complete submission text file 0001193125-20-298745.txt   2091570
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 201330525
SIC: 2834 Pharmaceutical Preparations